COVID-19 has been officially declared as a pandemic by the WHO. italy was the first european country to be strongly affected by this outbreak. all elective and health promotion activities were reduced. accordingly, italian breast units and breast cancer (BC) screening programs scaled down significantly their activities. the aim of this study was to evaluate measures that could potentially reduce the clinical impact of COVID-19 on BC patients. temporary recommendations are needed that could assist specialists in preventing COVID-19 infection and optimizing resources for diagnosis and treatment of BC patients.

Buonomo, O.c., Materazzo, M., Pellicciaro, M., Caspi, J., Piccione, E., Vanni, G. (2020). Tor vergata university-hospital in the beginning of COVID-19-era: Experience and recommendation for breast cancer patients. IN VIVO, 34(3 Suppl), 1661-1665 [10.21873/invivo.11958].

Tor vergata university-hospital in the beginning of COVID-19-era: Experience and recommendation for breast cancer patients

Buonomo, O. C.;Materazzo, M.;Pellicciaro, M.;Caspi, J.;Piccione, E.;Vanni, G.
2020-01-01

Abstract

COVID-19 has been officially declared as a pandemic by the WHO. italy was the first european country to be strongly affected by this outbreak. all elective and health promotion activities were reduced. accordingly, italian breast units and breast cancer (BC) screening programs scaled down significantly their activities. the aim of this study was to evaluate measures that could potentially reduce the clinical impact of COVID-19 on BC patients. temporary recommendations are needed that could assist specialists in preventing COVID-19 infection and optimizing resources for diagnosis and treatment of BC patients.
2020
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/18
Settore MEDS-06/A - Chirurgia generale
English
Breast cancer
COVID-19
Italy
Italy
Screening program
Tailored treatment
Buonomo, O.c., Materazzo, M., Pellicciaro, M., Caspi, J., Piccione, E., Vanni, G. (2020). Tor vergata university-hospital in the beginning of COVID-19-era: Experience and recommendation for breast cancer patients. IN VIVO, 34(3 Suppl), 1661-1665 [10.21873/invivo.11958].
Buonomo, Oc; Materazzo, M; Pellicciaro, M; Caspi, J; Piccione, E; Vanni, G
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
in_vivo-34-1661[1].pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 94.04 kB
Formato Adobe PDF
94.04 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/394046
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 35
social impact